BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• FDA

  Aclaris Nabs FDA Approval for ESKATA Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs)

  SKs are non-cancerous skin growths that affect more than 83 million American adults and can be an aesthetic skin concern.

  December 15, 2017

   · 

  7 min read
• Genetown

  TESARO Announces Availability of ZEJULA (niraparib) for Women With Recurrent Ovarian Cancer in Germany

  ZEJULA is the first once-daily, oral PARP inhibitor to be approved in Europe that does not require BRCA mutation or biomarker testing.

  December 15, 2017

   · 

  8 min read
• Policy

  Takeda And Tigenix Announce That Cx601 (Darvadstrocel) Has Received a Positive CHMP Opinion to Treat Complex Perianal Fistulas in Crohn’s Disease

  This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe.

  December 15, 2017

   · 

  12 min read
• Beleave Provides Business Update

  The issuance of a sales license under the ACMPR is in part dependent upon the completion of a satisfactory pre-sale inspection by Health Canada.

  December 15, 2017

   · 

  2 min read
• Drug Development

  Espero BioPharma Provides Corporate Update and 2018 Objectives

  Espero BioPharma today announced a strategic update on its clinical and regulatory strategies for tecarfarin, an oral anticoagulant.

  December 15, 2017

   · 

  6 min read
• BioMidwest

  Aratana Therapeutics Announces Study Results for AT-016

  Aratana has received top-line pivotal field effectiveness study results for AT-016, an investigational adipose-derived allogeneic stem cell therapeutic candidate for the control of clinical signs associated with osteoarthritis.

  December 15, 2017

   · 

  7 min read
• OSE Immunotherapeutics Receives a Grant From French Government Program “Fonds Unique Interministériel” to Explore New Cytotoxic Antibodies

  This collaborative program is focused on developing innovative tests to explore and to measure the cytotoxicity of monoclonal antibodies.

  December 15, 2017

   · 

  4 min read
• Pharm Country

  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) of 10,000 Shares of Its Common Stock

  The awards were made pursuant to the NASDAQ inducement grant exception as a component of the new hires’ employment compensation.

  December 15, 2017

   · 

  1 min read
• Business

  NOTICE TO THE MARKET: Grupo Biotoscana Announces Hiring of Executive VP of R&D

  Grupo Biotoscana announces to its shareholders and the market in general that has hired Ivan French as Executive VP of Research and Development.

  December 15, 2017

   · 

  2 min read
• Valeant and One of Its Subsidiaries Announce Early Tender Results and Early Settlement Date on December 18 for Cash Tender Offers for Senior Notes

  Valeant announced today the results to date of the pending cash tender offers by Valeant and Valeant Pharmaceuticals International to purchase up to $1,500,000,000 aggregate principal amount

  December 15, 2017

   · 

  9 min read